.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The pace of hospital expansion in India has accelerated significantly due to recent multi-billion rupee investments. Specifically, US private equity giant KKR infused an additional ₹1,750 crore into Baby Memorial Hospital (BMH) via a rights issue. This latest funding round strengthens the Kozhikode-based healthcare provider's presence across the southern region. Consequently, KKR’s total capital commitment to the chain has now surpassed ₹5,100 crore since its initial stake purchase in 2024.
BMH is utilizing these funds to aggressively pursue both organic and inorganic growth. For example, the group recently secured a controlling interest in Star Hospitals, outbidding Fortis Healthcare in the process. Furthermore, this acquisition followed the successful purchase of Meitra Hospital in September last year. As a result, the hospital chain now operates nine facilities across Kerala, Tamil Nadu, and Telangana.
The group’s current footprint includes six facilities in Kerala, one in Tamil Nadu, and two in Telangana. Moreover, the total bed capacity will soon reach 3,000 across these units. This scaling effort reflects KKR’s broader strategy of building dominant regional platforms. They previously demonstrated this model through the successful merger and expansion of Max Healthcare and Radiant Life Care. By consolidating high-performing assets, they aim to drive both clinical excellence and financial value.
Additionally, experts expect the chain to achieve annual revenues of ₹2,500 crore by the end of the current financial year. Such financial milestones provide the necessary leverage for future acquisitions and infrastructure upgrades. However, the focus remains on maintaining high standards of tertiary care. This approach ensures that the rapid growth does not compromise patient outcomes or clinical quality. Therefore, the hospital group continues to invest in advanced medical technology and robotic surgery centers.
Q1: How many hospitals does the BMH network currently operate?
The network currently operates nine hospitals located across Kerala, Tamil Nadu, and Telangana.
Q2: Who is the physician leading Baby Memorial Hospital?
Dr. KG Alexander is the founder and current group chairman of the hospital chain.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
KKR invests ₹1,750 crore in Baby Memorial Hospital to drive hospital expansion in India, targeting 3,000 beds and acquiring Star Hospitals....
5 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
